LAPTM5通过稳定粉红中的STING加剧LL-37引起的STING介导炎症
Wenyue Huang1,2, Hailun He3, Haien Wu4
1Department of Dermatology, Shengjing Hospital of China Medical University, Shenyang, China.
Communications biology
|October 14, 2025
概括
LAPTM5稳定了STING,一种与疹等皮肤炎症有关的蛋白质. 抑制LAPTM5或STING可以减少粉红病症状,这表明这种慢性炎症性皮肤疾病的新治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
背景情况:
- 红是一种慢性炎症性皮肤疾病.
- LL-37和STING信号传递与疹病变发生有关.
- STING (干扰素基因刺激器) 是先天免疫系统中关键的DNA传感器.
研究的目的:
- 研究LAPTM5,一种与STING相互作用的蛋白质在疹中所起的作用.
- 确定LAPTM5在调节STING活动中的机制.
- 评估LAPTM5和STING抑制作为粉红病的治疗策略.
主要方法:
- 在病患者病变和小鼠模型中核DNA碎片化的分析.
- 在巨细胞中量化LAPTM5和STING表达.
- 在LAPTM5中断时评估STING信号和炎症性细胞因子的产生.
- 共同免疫沉以研究LAPTM5-STING相互作用和无处不在.
- 在粉红病样小鼠模型中对STING抗剂H-151和LAPTM5敲击的评估.
主要成果:
- 在疹病变和模型中增加核DNA碎片化,LAPTM5和STING水平.
- 通过LAPTM5 Knockdown,可以降低STING水平,信号和炎症.
- 通过抑制其降解,LAPTM5稳定了STING.
- 无论是STING抑制还是LAPTM5敲击都能改善类似于粉红病的表型.
结论:
- LAPTM5充当了刺痛稳定剂,加剧了粉红病中刺痛驱动的炎症.
- 准LAPTM5或STING为粉红治疗提供了潜在的治疗途径.
更多相关视频
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
8.1K
03:47Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
Published on: September 27, 2024
1.4K
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
